Acadia Pharma (ACAD) Misses Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $16.31 -1.69%
EPS Growth %: +122.2%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +122.2%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.40), $0.13 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $4 thousand versus the consensus estimate of $80 thousand.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- SPS Commerce (SPSC) Tops Q1 EPS by 12c
- Universal Logistics Holdings, Inc. (ULH) Tops Q1 EPS by 136c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
